State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, and West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, 610041, PR China.
Department of Urology, Second Affiliated Hospital of Chengdu Medical College (China National Nuclear Corporation 416 Hospital), Chengdu, Sichuan, China.
Cancer Lett. 2018 Apr 1;418:250-259. doi: 10.1016/j.canlet.2018.01.010. Epub 2018 Jan 9.
Dysregulation of microRNAs (miRNAs) has long been implicated in tumorigenesis, whereas the underlying mechanisms remain largely unknown. Oxidative stress is a hallmark of cancer that involved in multiple pathophysiological processes, including the aberrant regulation of miRNAs. Compelling evidences have implied complicated interplay between reactive oxygen species (ROS) and miRNAs. Indeed, ROS induces carcinogenesis through either reducing or increasing the miRNA level, leading to the activation of oncogenes or silence of tumor suppressors, respectively. In turn, miRNAs target ROS productive genes or antioxidant responsive elements to affect cellular redox balance, which contributes to establishing a microenvironment favoring cancer cell growth and metastasis. Both miRNAs and ROS have been identified as potential biomarkers and therapeutic targets in human malignancies, and comprehensive understanding of the molecular events herein will facilitate the development of novel cancer therapeutic strategies.
miRNAs 的失调长期以来一直被认为与肿瘤发生有关,但其潜在机制在很大程度上仍不清楚。氧化应激是癌症的一个标志,涉及多种病理生理过程,包括 miRNA 的异常调节。有令人信服的证据表明活性氧(ROS)和 miRNA 之间存在复杂的相互作用。事实上,ROS 可以通过降低或增加 miRNA 水平来诱导致癌作用,分别导致癌基因的激活或肿瘤抑制因子的沉默。反过来,miRNAs 靶向 ROS 产生基因或抗氧化反应元件,以影响细胞氧化还原平衡,有助于建立有利于癌细胞生长和转移的微环境。miRNAs 和 ROS 都已被确定为人类恶性肿瘤的潜在生物标志物和治疗靶点,全面了解其中的分子事件将有助于开发新的癌症治疗策略。